1-16 of 16
Boaz Hirshberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Erratum. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care 2021;44:1433–1442

Rajaa Nahra, Tao Wang, Kishore M. Gadde, Jan Oscarsson, Michael Stumvoll, Lutz Jermutus, Boaz Hirshberg, Philip Ambery
Journal: Diabetes Care
Diabetes Care 2022;45(12):3112
https://doi.org/10.2337/dc22-er12
Published: 13 October 2022
View articletitled, Erratum. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care 2021;44:1433–1442
Open the PDF for Erratum. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care 2021;44:1433–1442 in another window
Journal Articles

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Rajaa Nahra, Tao Wang, Kishore M. Gadde, Jan Oscarsson, Michael Stumvoll, Lutz Jermutus, Boaz Hirshberg, Philip Ambery
Journal: Diabetes Care
Diabetes Care 2021;44(6):1433–1442
https://doi.org/10.2337/dc20-2151
Published: 18 June 2021
View articletitled, Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Open the PDF for Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study in another window
Journal Articles

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Gil Leibowitz, Deepak L. Bhatt, Avivit Cahn, Boaz Hirshberg, Cheryl Wei, KyungAh Im, Aliza Rozenberg, Ilan Yanuv, Christina Stahre, Kausik K. Ray, Nayyar Iqbal, Eugene Braunwald, Benjamin M. Scirica, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2017;40(1):69–76
https://doi.org/10.2337/dc16-0621
Published: 17 October 2016
View articletitled, Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Open the PDF for Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial

Avivit Cahn, Itamar Raz, Ofri Mosenzon, Gil Leibowitz, Ilan Yanuv, Aliza Rozenberg, Nayyar Iqbal, Boaz Hirshberg, Mikaela Sjostrand, Christina Stahre, KyungAh Im, Estella Kanevsky, Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald
Journal: Diabetes Care
Diabetes Care 2016;39(8):1329–1337
https://doi.org/10.2337/dc15-2763
Published: 23 May 2016
View articletitled, Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial
Open the PDF for Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Cheryl Wei, Jaime Davidson, Benjamin M. Scirica, Ilan Yanuv, Aliza Rozenberg, Boaz Hirshberg, Avivit Cahn, Christina Stahre, Krzysztof Strojek, Deepak L. Bhatt, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2015;38(11):2142–2150
https://doi.org/10.2337/dc15-1068
Published: 10 September 2015
View articletitled, Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial
Open the PDF for Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial in another window
Journal Articles

Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes

Stephan Matthaei, Doina Catrinoiu, Aleksander Celiński, Ella Ekholm, William Cook, Boaz Hirshberg, Hungta Chen, Nayyar Iqbal, Lars Hansen
Journal: Diabetes Care
Diabetes Care 2015;38(11):2018–2024
https://doi.org/10.2337/dc15-0811
Published: 31 August 2015
View articletitled, Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
Open the PDF for Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes

Chantal Mathieu, Aurelian Emil Ranetti, Danshi Li, Ella Ekholm, William Cook, Boaz Hirshberg, Hungta Chen, Lars Hansen, Nayyar Iqbal
Journal: Diabetes Care
Diabetes Care 2015;38(11):2009–2017
https://doi.org/10.2337/dc15-0779
Published: 05 August 2015
View articletitled, Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes
Open the PDF for Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial

Lawrence A. Leiter, Hwee Teoh, Eugene Braunwald, Ofri Mosenzon, Avivit Cahn, K.M. Prasanna Kumar, Alena Smahelova, Boaz Hirshberg, Christina Stahre, Robert Frederich, Francois Bonnici, Benjamin M. Scirica, Deepak L. Bhatt, Itamar Raz, for the SAVOR-TIMI 53 Steering Committee and Investigators
Journal: Diabetes Care
Diabetes Care 2015;38(6):1145–1153
https://doi.org/10.2337/dc14-2868
Published: 10 March 2015
View articletitled, Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial
Open the PDF for Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

Jacob A. Udell, Deepak L. Bhatt, Eugene Braunwald, Matthew A. Cavender, Ofri Mosenzon, Ph. Gabriel Steg, Jaime A. Davidson, Jose C. Nicolau, Ramon Corbalan, Boaz Hirshberg, Robert Frederich, KyungAh Im, Amarachi A. Umez-Eronini, Ping He, Darren K. McGuire, Lawrence A. Leiter, Itamar Raz, Benjamin M. Scirica
Journal: Diabetes Care
Diabetes Care 2015;38(4):696–705
https://doi.org/10.2337/dc14-1850
Published: 31 December 2014
View articletitled, Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial
Open the PDF for Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin

Julio Rosenstock, Lars Hansen, Pamela Zee, Yan Li, William Cook, Boaz Hirshberg, Nayyar Iqbal
Journal: Diabetes Care
Diabetes Care 2015;38(3):376–383
https://doi.org/10.2337/dc14-1142
Published: 28 October 2014
View articletitled, Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin
Open the PDF for Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin in another window
Includes: Supplementary data
Journal Articles

Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin

Itamar Raz, Deepak L. Bhatt, Boaz Hirshberg, Ofri Mosenzon, Benjamin M. Scirica, Amarachi Umez-Eronini, KyungAh Im, Christina Stahre, Alona Buskila, Nayyar Iqbal, Norton Greenberger, Markus M. Lerch
Journal: Diabetes Care
Diabetes Care 2014;37(9):2435–2441
https://doi.org/10.2337/dc13-2546
Published: 07 August 2014
View articletitled, Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin
Open the PDF for Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin in another window
Includes: Supplementary data
Journal Articles

Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations

Boaz Hirshberg, MD, Arie Katz, MD
Journal: Diabetes Care
Diabetes Care 2013;36(Supplement_2):S253–S258
https://doi.org/10.2337/dcS13-2041
Published: 17 July 2013
View articletitled, Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations
Open the PDF for Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations in another window
Journal Articles

Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs

Boaz Hirshberg, MD, Itamar Raz, MD
Journal: Diabetes Care
Diabetes Care 2011;34(Supplement_2):S101–S106
https://doi.org/10.2337/dc11-s202
Published: 22 April 2011
View articletitled, Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
Open the PDF for Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs in another window
Journal Articles

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : Response to Charles and Selam

Boaz Hirshberg, MD, Kristina I. Rother, MD, Benigno J. Digon, III, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2004;27(5):1250–1251
https://doi.org/10.2337/diacare.27.5.1250
Published: 01 May 2004
View articletitled, Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : Response to Charles and Selam
Open the PDF for Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : Response to Charles and Selam in another window
Journal Articles

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience

Boaz Hirshberg, MD, Kristina I. Rother, MD, Benigno J. Digon, III, MD, Janet Lee, MD, Jason L. Gaglia, MD, Kenneth Hines, BS, MT (ASCP), Elizabeth J. Read, MD, Richard Chang, MD, Bradford J. Wood, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2003;26(12):3288–3295
https://doi.org/10.2337/diacare.26.12.3288
Published: 01 December 2003
View articletitled, Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience
Open the PDF for Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience in another window
Journal Articles

Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient

Benigno J. Digon, III, MD, Kristina I. Rother, MD, Boaz Hirshberg, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3191
https://doi.org/10.2337/diacare.26.11.3191
Published: 01 November 2003
View articletitled, Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient
Open the PDF for Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient in another window